Patent · US Expired

Immunoglobin-like domains with increased half lives

US6821505B2 · kind B2 · utility

369Cited by
1References
5Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 20, 2001
Grant dateNov 23, 2004
Priority date
Expiry dateJan 19, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are recombinant vectors encoding immunoglobulin-like domains and portions thereof, such as antibody Fc-hinge fragments, subfragments and mutant domains with extended biological half lives. Methods of producing large quantities of such domains, heterodimers, and fusion proteins following expression by host cells are also reported. Described are antibody Fc and Fc-hinge domains, which have the same in vivo stability as intact antibodies; and domains engineered to have increased in vivo half lives. These DNA constructs and protein domains will be useful as templates for in vitro mutagenesis and high resolution structural studies; for immunization and vaccination; and for the production of recombinant antibodies or chimeric proteins with increased stability and longevity for therapeutic and diagnostic uses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.